Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
5.16
-0.24 (-4.44%)
At close: Apr 28, 2026, 4:00 PM EDT
5.22
+0.06 (1.16%)
After-hours: Apr 28, 2026, 7:51 PM EDT
Cybin Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
258.18M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Arcturus Therapeutics Holdings | 82.03M |
| Compugen | 72.76M |
| Codexis | 70.39M |
| Coherus Oncology | 42.17M |
| C4 Therapeutics | 35.95M |
| Alector | 21.05M |
| SAB Biotherapeutics | 114.70K |
HELP News
- 18 hours ago - Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
- 5 days ago - Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan - GlobeNewsWire
- 8 days ago - How Trump's psychedelics executive order could unlock stalled cannabis reform - CNBC
- 8 days ago - Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions - GlobeNewsWire
- 8 days ago - Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer - GlobeNewsWire
- 8 days ago - Psychedelic drug makers rally as Trump orders FDA to expedite reviews - Reuters
- 12 days ago - Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs - GlobeNewsWire
- 6 weeks ago - Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer - GlobeNewsWire